All News Immuron Limited

Equities

Market Closed - Australian S.E. Other stock markets 01:40:01 2024-04-30 am EDT			5-day change	1st Jan Change
0.1 ^AUD	0.00%		0.00%	+29.87%

Apr. 10	Immuron Limited Provides Sales Results for the Quarter and Year to Date Ended March 2024	CI
Apr. 10	Immuron's Global Sales Climb 51% in March Quarter; Shares Surge 18%	MT

Immuron to host Live Virtual Event	Apr. 15	GL
Immuron Travelan® sales continued strong growth	Apr. 10	GL
Immuron Limited Provides Sales Results for the Quarter and Year to Date Ended March 2024	Apr. 10	CI
Immuron's Global Sales Climb 51% in March Quarter; Shares Surge 18%	Apr. 09	MT
Sector Update: Health Care Stocks Gain Late Afternoon	Mar. 07	MT
Sector Update: Health Care	Mar. 07	MT
Top Midday Gainers	Mar. 07	MT
Top Premarket Gainers	Mar. 07	MT
Immuron Moving Anti-Diarrhea Drug to Phase Three Trials	Mar. 07	MT
Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US	Mar. 07	GL
Immuron Limited Announces Positive Results Support Travelan Progress to Phase 3 Clinical Trials in the US	Mar. 07	CI
Immuron Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 27	CI
Immuron Presentation Australian Biologics Festival 2024	Feb. 21	GL
Immuron Presentation Australian Biologics Festival 2024	Feb. 21	AQ
Immuron achieves record Travelan® sales	Feb. 13	GL
Immuron achieves record Travelan® sales	Feb. 13	AQ
Immuron Limited Reports Unaudited Net Sales Results for the Year to Date Ended January 2024	Feb. 13	CI
Immuron's Travelan Immune Supplement Registers AU$2.7 Million Sales in YTD January	Feb. 12	MT
Immuron CEO, Steven Lydeamore Investor Webinar Presentation	Feb. 08	GL
Immuron CEO, Steven Lydeamore Investor Webinar Presentation	Feb. 08	AQ

No results for this search